Delivery Vehicles

Probiotics are live microorganisms which confer a health benefit on the host when administered in an adequate amount. Over the past decades, the market size of probiotics has greatly increased as modern consumer concern about health-promoting effect of nutraceuticals. Since probiotic-containing products in general do not require Food and Drug Administration approval, they are commonly available in the market in various food formats such as fermented milk, cheese, yogurt and juice. In recent years, probiotics have been extensively studied as a treatment option of various diseases such as obesity, diabetes, cancer, human immunodeficiency virus infection, irritable bowel syndrome. For probiotics to exert beneficial activities, a sufficient amount of probiotics should be alive and functionally active at the site of action as well as in a product. Probiotics are recommended to be present at a minimum level of 6 log colony forming unit (CFU)/g in a food product or 7 log CFU/g at the point of delivery. Due to the vulnerability of probiotics to harsh conditions during manufacturing, storage and passage through the gastrointestinal (GI) tract, however, it is difficult that viable probiotics successfully exert beneficial activities. During manufacturing and/or storage, the viability of probiotics can be negatively affected by several factors such as temperature, water activity and other food ingredients. Specifically, high temperature during manufacturing processes is a main reason for reduced viability because most probiotics have low thermo-resistance. Maintaining viability in the stomach is another difficult task for probiotics to reach the target site because most of probiotics die or lose their functionality at acidic conditions. Next, survived probiotics should be released at the target site of action which is usually small or large intestine. Therefore, an ideal probiotic delivery system should protect probiotics from adverse conditions during fabrication and storage and in the acidic gastric environment so that the sufficient amount of probiotics is available in the site of action.

  • Probiotics as antigen delivery vehicles
  • Probiotics as delivery vehicles for neuroactive compounds
  • Encapsulation of probiotics in to carrier material
  • Non microencapsulation-based technology
  • Food Formats for effective delivery of Probiotics
  • Probiotic delivery systems
  • Recent trends of probiotics delivery systems
  • Dairy products as delivery vehicle for probiotics and biogenic substances
  • Oral Vaccine Delivery by Recombinant Spore Probiotics
  • LAB as Vehicles for Anti-IBD Compounds

Related Conference of Delivery Vehicles

February 20-21, 2025

8th International Conference on Food Safety and Health

Amsterdam, Netherlands
February 24-25, 2025

31st International Conference on Clinical Nutrition

London, UK
March 10-11, 2025

7th World Summit on Health Nutrition

Paris, France
June 24-25, 2025

24th International Congress on Nutrition and Health

Amsterdam, Netherlands
July 07-08, 2025

32nd European Nutrition and Dietetics Conference

Zurich, Switzerland
September 08-09, 2025

24th World Congress on Nutrition and Food Chemistry

Frankfurt, Germany
September 15-16, 2025

29th World Congress on Nutrition and Food Sciences

Aix-en-Provence, France

Delivery Vehicles Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in